{
  "id": "R44916",
  "type": "CRS Report",
  "typeId": "REPORTS",
  "number": "R44916",
  "active": true,
  "source": "EveryCRSReport.com",
  "versions": [
    {
      "source": "EveryCRSReport.com",
      "id": 586007,
      "date": "2017-08-16",
      "retrieved": "2020-01-02T14:12:50.324285",
      "title": "Public Health Service Agencies: Overview and Funding (FY2016-FY2018)",
      "summary": "Within the Department of Health and Human Services (HHS), eight agencies are designated components of the U.S. Public Health Service (PHS). The PHS agencies are funded primarily with annual discretionary appropriations. They also receive significant amounts of funding from other sources, including mandatory funds from the Patient Protection and Affordable Care Act (ACA; P.L. 111-148, as amended), user fees, and third-party reimbursements (collections).\nThe Agency for Healthcare Research and Quality (AHRQ) funds research on improving the quality and delivery of health care. For more than a decade prior to FY2015, AHRQ did not receive its own annual appropriation. Instead, it relied on redistributed (\u201cset-aside\u201d) discretionary funds from other PHS agencies for most of its funding, with supplemental amounts from the ACA\u2019s mandatory Patient-Centered Outcomes Research Trust Fund (PCORTF). Since FY2015, AHRQ has received an annual appropriation in lieu of any set-aside funds. The agency\u2019s FY2017 funding level of $417 million was $11 million less than the FY2016 level of $428 million. \nThe Centers for Disease Control and Prevention (CDC) is the federal government\u2019s lead public health agency. CDC obtains its funding from multiple sources besides discretionary appropriations. The Agency for Toxic Substances and Disease Registry (ATSDR) investigates the public health impact of exposure to hazardous substances. ATSDR is headed by the CDC director and included in the discussion of CDC in this report. The CDC/ATSDR funding level decreased from $12.2 billion in FY2016 to $12.1 billion in FY2017.\nThe Food and Drug Administration (FDA) regulates drugs, medical devices, food, and tobacco products, among other consumer products. The agency is funded with annual discretionary appropriations and industry user fees. The agency\u2019s funding levels for FY2016 and FY2017 remained constant at about $4.7 billion, with user fees accounting for 41% of FDA\u2019s total FY2017 funding.\nThe Health Resources and Services Administration (HRSA) funds programs and systems that provide health care services to the uninsured and medically underserved. HRSA, like CDC, relies on funding from several different sources. The agency\u2019s funding decreased from $10.8 billion in FY2016 to $10.7 billion in FY2017. \nThe Indian Health Service (IHS) supports a health care delivery system for Native Americans. IHS\u2019s funding, which includes discretionary appropriations and collections from third-party payers of health care, increased between FY2016 and FY2017 from $6.2 billion to $6.4 billion. Appropriations increased during that period, while collections stayed the same in both fiscal years.\nThe National Institutes of Health (NIH) funds basic, clinical, and translational biomedical and behavioral research. NIH gets more than 99% of its funding from discretionary appropriations. Recent increases in NIH\u2019s annual appropriations have boosted its funding level to a new high of $34.1 billion in FY2017, compared with $32.3 billion in FY2016.\nThe Substance Abuse and Mental Health Services Administration (SAMHSA) funds mental health and substance abuse prevention and treatment services. SAMHSA\u2019s funding, about 95% of which comes from discretionary appropriations, was approximately $3.8 billion in FY2016 and $4.3 billion in FY2017.\nThis report supersedes two earlier products, both of which remain available: CRS Report R43304, Public Health Service Agencies: Overview and Funding (FY2010-FY2016), and CRS Report R44505, Public Health Service Agencies: Overview and Funding (FY2015-FY2017).",
      "type": "CRS Report",
      "typeId": "REPORTS",
      "active": true,
      "formats": [
        {
          "format": "HTML",
          "encoding": "utf-8",
          "url": "https://www.crs.gov/Reports/R44916",
          "sha1": "e2cc9c8418568ded6de8c5c689d8fec248b4ae52",
          "filename": "files/20170816_R44916_e2cc9c8418568ded6de8c5c689d8fec248b4ae52.html",
          "images": {}
        },
        {
          "format": "PDF",
          "encoding": null,
          "url": "https://www.crs.gov/Reports/pdf/R44916",
          "sha1": "a55864b368ab021aef7483e36c6f4e92733a85fa",
          "filename": "files/20170816_R44916_a55864b368ab021aef7483e36c6f4e92733a85fa.pdf",
          "images": {}
        }
      ],
      "topics": [
        {
          "source": "IBCList",
          "id": 4788,
          "name": "Health Care Delivery"
        },
        {
          "source": "IBCList",
          "id": 4921,
          "name": "Labor, HHS, & Education Appropriations"
        }
      ]
    }
  ],
  "topics": [
    "Appropriations",
    "Foreign Affairs",
    "Health Policy"
  ]
}